# Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement

Study · id `cardio:ct-nct05431972` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05431972](<https://clinicaltrials.gov/study/NCT05431972>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05431972

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 257 participants.

## Technical summary

Registry record NCT05431972. Randomized; no masking; primary purpose diagnostic. Start 2022-11-01 (actual); primary completion 2024-09-13 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 257 participants (enrolled count; ClinicalTrials.gov record NCT05431972, source copy `cardio:ctgov-nct05431972-2025-12-15`, retrieved 2026-10-26)
- Started: 2022-11-01 (actual) (ClinicalTrials.gov record NCT05431972, source copy `cardio:ctgov-nct05431972-2025-12-15`, retrieved 2026-10-26)
- Primary completion: 2024-09-13 (actual) (ClinicalTrials.gov record NCT05431972, source copy `cardio:ctgov-nct05431972-2025-12-15`, retrieved 2026-10-26)
- Completion: 2024-09-13 (actual) (ClinicalTrials.gov record NCT05431972, source copy `cardio:ctgov-nct05431972-2025-12-15`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT05431972, source copy `cardio:ctgov-nct05431972-2025-12-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05431972-2025-12-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cardea SOLOTM for Paroxysmal Atrial Fibrillation Diagnosis in ESUS Patients With Left Atrial Enlargement
- Condition: Embolic Stroke of Undetermined Source
- Intervention (Device): Cardea SOLO
- Intervention (Device): 12 Lead EKG
- Lead sponsor: Asan Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Asan Medical Center (`cardio:org-asan-medical-center`)

## Provenance

Content hash: 34dde06c8a96792320f82837f49e4b8e7eb78ccbd6e117966c25b021850257f0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
